KLIFO advisory moves to Symbion Frederiksberg – join our reception on 3rd September 2026
KLIFO advisory moves to Symbion Frederiksberg – join our reception on 3rd September 2026.
KLIFO advisory’s team of experienced drug development consultants has moved to Symbion, which marks an exciting new chapter for the team.
Our advisory team works with clients throughout the drug development journey, combining tested judgment, proactive risk management and committed partnerships to help projects maintain momentum.
The new location at Symbion places us at the heart of a vibrant life science and biotech community, alongside like-minded companies, clients and potential partners.
The move also comes as KLIFO prepares to leave our former Smedeland site in Glostrup. While advisory establishes its new base at Frederiksberg, our other activities will be consolidated at our Abildager location, where our state-of-the-art CTS facility opened in 2025.
To mark the move, KLIFO advisory will welcome clients and partners to the new offices at Symbion Frederiksberg on September 3, where we will share more about our advisory services, partnerships and approach to keeping drug development projects moving forward.
We look forward to welcoming you to our new surroundings. For more information, view the invite here.
